In vitro evaluation of mucoadhesive films for gingival administration of lidocaine

AAPS PharmSciTech

Volumn 14, Issue 4, 2013, Pages 1279-1283

  Padula, Cristina ^a   Pozzetti, Laura ^a   Traversone, Valeria ^a   Nicoli, Sara ^a   Santi, Patrizia ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Buccal delivery; Esophageal epithelium; Lidocaine; Permeation enhancers; Polymeric films

Indexed keywords

ADHESIVE AGENT; LIDOCAINE; PENETRATION ENHANCING AGENT; POLYACRYLIC ACID;

ADHESION; AQUEOUS SOLUTION; ARTICLE; CHEEK MUCOSA; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG RETENTION; DRUG TRANSPORT; ESOPHAGUS MUCOSA; EVALUATION STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INTRAGINGIVAL DRUG ADMINISTRATION; LIQUID CHROMATOGRAPHY; MUCOADHESIVE FILM; NEEDLESTICK INJURY; NONHUMAN; PERMEABILITY BARRIER; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

ADMINISTRATION, BUCCAL; ALGORITHMS; ANESTHETICS, LOCAL; ANIMALS; CHEEK; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DELIVERY SYSTEMS; EPITHELIUM; ESOPHAGUS; GINGIVA; LIDOCAINE; MODELS, STATISTICAL; MOUTH MUCOSA; PERMEABILITY; RESINS, SYNTHETIC; SWINE; TISSUE ADHESIVES;

EID: 84893700888     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-013-0020-8     Document Type: Article

References (34)

1. Milgrom P, Coldwell SE, Getz T, Weinstein P, Ramsay DS. Four dimensions of fear of dental injections. J Am Dent Assoc. 1997;128:756-66.
2. Meechan JG. Intraoral topical anesthesia. Periodontology. 2008;46:56-79.
3. Rosivack RG, Koenigsberg SR, Maxwell KC. An analysis of the effectiveness of two topical anesthetics. Anesth Prog. 1990;37(6):290-2.
4. Carr MP, Horton JE. Clinical evaluation and comparison of 2 topical anesthetics for pain caused by needle sticks and scaling and root planing. J Periodontol. 2001;72(4):479-84.
5. Carr MP, Horton JE. Evaluation of a transoral delivery system for topical anesthesia. J Am Dent Assoc. 2001;132(12):1714-9.
6. Yaacob HB, Noor GM, Malek SN. The pharmacological effect of xylocaine topical anaesthetic-a comparison with a placebo. Singapore Dent J. 1981;6(2):55-7.
7. Padula C, Colombo G, Nicoli S, Catellani P, Massimo G, Santi P. Bioadhesive film for the transdermal delivery of lidocaine: in vitro and in vivo behavior. J Control Release. 2003;88:277-85.
8. Diaz Del Consuelo I, Pizzolato GP, Falson F, Guy RH, Jacques Y. Evaluation of pig esophageal mucosa as a permeability barrier model for buccal tissue. J Pharm Sci. 2005;94(12):2777-88.
9. Peh KK, Wong CF. Polymeric films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties. J Pharm Pharmaceut Sci. 1999;2(2):53-61.
10. Baker RW, Londsdale HK. Controlled release of biologically active agents. In: Tanquary AC, Lacey RE, editors. Controlled release of biologically active agents. New York: Plenum Press; 1974.
11. USP. United States Pharmacopeia and National Formulary USP 34-NF 29 Rockville, MD. 2011.
12. Shojaei AH. Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharmaceut Sci. 1998;1(1):15-30.
13. Diaz Del Consuelo I, Jacques Y, Pizzolato GP, Guy RH, Falson F. Comparison of the lipid composition of porcine buccal and esophageal permeability barriers. Arch Oral Biol. 2005;50(12):981-7.
14. Diaz Del Consuelo I, Falson F, Guy RH, Jacques Y. Transport of fentanyl through pig buccal and esophageal epithelia in vitro. Influence of concentration and vehicle pH. Pharm Res. 2005;22(9):1525-9.
15. Diaz Del Consuelo I, Falson F, Guy RH, Jacques Y. Ex vivo evaluation of bioadhesive films for buccal delivery of fentanyl. J Control Release. 2007;123(2):135-40.
16. Caon T, Simoes CM. Effect of freezing and type of mucosa on ex vivo drug permeability parameters. AAPS PharmSciTech. 2011;12(2):587-92.
17. Kokate A, Li X, Jasti B. HPLC detection of marker compounds during buccal permeation enhancement studies. J Pharm Biomed Anal. 2008;47(1):190-4.
18. Franz-Montan M, Cereda CM, Gaspari A, Da Silva CM, De Araujo DR, Padula C, et al. Liposomal-benzocaine gel formulation: correlation between in vitro assays and in vivo topical anesthesia in volunteers. J Liposome Res. 2013;23(1):54-60.
19. Salamat-Miller N, Chittchang M, Johnston TP. The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev. 2005;57(11):1666-91.
20. Padula C, Nicoli S, Colombo P, Santi P. Single-layer transdermal film containing lidocaine: modulation of drug release. Eur J Pharm Biopharm. 2007;66:422-8.
21. Nash RA, Metha DB, Matias JR, Orentreich N. The possibility of lidocaine ion pair absorption through excised hairless mouse skin. Skin Pharmacol Appl. 1992;5(3):160-70.
22. Van Der Bijl P, Penkler L, Van Eyk AD. Permeation of sumatriptan through human vaginal and buccal mucosa. Headache. 2000;40:137-41.
23. Thassu D, Vyas SP. Controlled transdermal occlusive delivery device of primaquine. Drug Dev Ind Pharm. 1993;19:1343-56.
24. Mak VH, Potts RO, Guy RH. Does hydration affect intercellular lipid organization in the stratum corneum? Pharm Res. 1991;8(8):1064-5.
25. Senel S, Hincal AA. Drug permeation enhancement via buccal route: possibilities and limitations. J Control Release. 2001;72(1-3):133-44.
26. Steward A, Bayley DL, Howes C. The effect of enhancers on the buccal absorption of hybrid (BDBB) alpha interferon. Int J Pharm. 1994;104:145-9.
27. Zhang J, Nin S, Ebert C, Stanley TH. An in vivo dog model for studying recovery kinetics of the buccal mucosa permeation barrier after exposure to permeation enhancers: apparent evidence of effective enhancement without tissue damage. Int J Pharm. 1994;101:15-22.
28. Artusi M, Santi P, Colombo P, Junginger HE. Buccal delivery of thiocolchicoside: in vitro and in vivo permeation studies. Int J Pharm. 2003;250(1):203-13.
29. Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2004;56(5):603-18.
30. Nicolazzo JA, Reed BL, Finnin BC. Buccal penetration enhancers-how do they really work? J Control Release. 2005;105(1-2):1-15.
31. Hu L, Damaj BB, Martin R, Michniak-Kohn BB. Enhanced in vitro transbuccal drug delivery of ondansetron HCl. Int J Pharm. 2011;404(1-2):66-74.
32. Nicolazzo JA, Reed BL, Finnin BC. Enhancing the buccal mucosal uptake and retention of triamcinolone acetonide. J Control Release. 2005;105(3):240-8.
33. Heemstra LB, Finnin BC, Nicolazzo JA. The buccal mucosa as an alternative route for the systemic delivery of risperidone. J Pharm Sci. 2010;99(11):4584-92.
34. Cid YP, Pedrazzi V, De Sousa VP, Pierre MB. In vitro characterization of chitosan gels for buccal delivery of celecoxib: influence of a penetration enhancer. AAPS PharmSciTech. 2012;13(1):101-11.